Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LASTING ANTITUMOR IMMUNITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 140 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nagai, M; Masuzawa, T
      Vaccination with MCP-1 cDNA transfectant on human malignant glioma in nudemice induces migration of monocytes and NK cells to the tumor

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. de Wilt, JHW; Bout, A; Eggermont, AMM; van Tiel, ST; de Vries, MW; ten Hagen, TLM; de Roos, WK; Valerio, D; van der Kaaden, ME
      Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats

      HUMAN GENE THERAPY
    3. Slovin, SR
      Vaccines as treatment strategies for relapsed prostate cancer - Approachesfor induction of immunity

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    4. Siebels, M; Meyer, G; Habicht, A; Meuer, SC; Moebius, U
      Simultaneous ligation of CD5 and CD28 with monoclonal antibodies restores impaired immunostimulatory function in human renal cell carcinoma

      UROLOGICAL RESEARCH
    5. Qian, SB; Li, Y; Qian, GX; Chen, SS
      Efficient tumor regression induced by genetically engineered tumor cells secreting interleukin-2 and membrane-expressing allogeneic MHC class I antigen

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    6. Reali, E; Greiner, JW; Corti, A; Gould, HJ; Bottazzoli, F; Paganelli, G; Schlom, J; Siccardi, AG
      IgEs targeted on tumor cells: Therapeutic activity and potential in the design of tumor vaccines

      CANCER RESEARCH
    7. Pardoll, DM
      Therapeutic vaccination for cancer

      CLINICAL IMMUNOLOGY
    8. Hardy, PA; Mazzini, MJ; Schweitzer, C; Lundstrom, K; Glode, LM
      Recombinant Semliki Forest Virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    9. Bjorkdahl, O; Dohlsten, M; Sjogren, HO
      Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1 beta induces tumor growth inhibition and an enhanced immunity againstthe wild-type B16 tumor

      CANCER GENE THERAPY
    10. Tanigawa, K; Yu, H; Sun, R; Nickoloff, BJ; Chang, AE
      Gene gun application in the generation of effector T cells for adoptive immunotherapy

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    11. Murata, S; Eguchi, Y; Mekata, E; Tani, T; Kodama, M
      Kinetics of cytokine gene expression during the in vitro CTL induction against a murine nonimmunogenic tumor

      ANTICANCER RESEARCH
    12. Kaufmann, AM; Gissmann, L; Simms, P; Schreckenberger, C; Qiao, L
      Comparison of cytokines and CD80 for enhancement of immunogenicity of cervical cancer cells

      IMMUNOBIOLOGY
    13. Carr-Brendel, V; Markovic, D; Ferrer, K; Smith, M; Taylor-Papadimitriou, J; Cohen, EP
      Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1

      CANCER RESEARCH
    14. Carr-Brendel, V; Markovic, D; Smith, M; Taylor-Papadimitriou, JT; Cohen, EP
      Immunity to breast cancer in mice immunized with X-irradiated breast cancer cells modified to secrete IL-12

      JOURNAL OF IMMUNOTHERAPY
    15. Li, Q; Chang, AE
      Adoptive T-cell immunotherapy of cancer

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    16. Palmer, K; Moore, J; Everard, M; Harris, JD; Rodgers, S; Rees, RC; Murray, AK; Mascari, R; Kirkwood, J; Riches, PG; Fisher, C; Thomas, JM; Harries, M; Johnston, SRD; Collins, MKL; Gore, ME
      Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

      HUMAN GENE THERAPY
    17. Kikuchi, T; Crystal, RG
      Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells

      HUMAN GENE THERAPY
    18. Sun, YS; Paschen, A; Schadendorf, D
      Cells-based vaccination against melanoma - background, preliminary results, and perspective

      JOURNAL OF MOLECULAR MEDICINE-JMM
    19. Rochlitz, C; Jantscheff, P; Bongartz, G; Dietrich, PY; Quiquerez, AL; Schatz, C; Mehtali, M; Courtney, M; Tartour, E; Dorval, T; Fridman, WH; Herrmann, R
      Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumors

      CANCER GENE THERAPY
    20. Nawrocki, S; Mackiewicz, A
      Genetically modified tumour vaccines - where we are today

      CANCER TREATMENT REVIEWS
    21. Kouraklis, G
      Progress in cancer gene therapy

      ACTA ONCOLOGICA
    22. Matsumoto, G; Sunamura, M; Shimamura, H; Kodama, T; Hashimoto, W; Kobari, M; Kato, K; Takeda, K; Yagita, H; Okumura, K; Hamada, H; Matsuno, S
      Adjuvant immunotherapy using fibroblasts genetically engineered to secreteinterleukin 12 prevents recurrence after surgical resection of establishedtumors in a murine adenocarcinoma model

      SURGERY
    23. Ribeiro, U; Whiteside, TL; Basse, PH; Safatle-Ribeiro, AV; Huneke, CE; Posner, MC
      Activated natural killer cell tumor retention and cytokine production in colon tumor using a tissue-isolated model

      JOURNAL OF SURGICAL RESEARCH
    24. Dong, XD; Abdel-Wahab, Z; Dematos, P; Fong, T; Pruitt, SK; Seigler, HF
      MCA106 fibrosarcoma cells transduced with granulocyte macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing thegrowth of hepatic metastases

      JOURNAL OF SURGICAL ONCOLOGY
    25. Tanaka, H; Yoshizawa, H; Yamaguchi, Y; Ito, K; Kagamu, H; Suzuki, E; Gejyo, F; Hamada, H; Arakawa, M
      Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells

      JOURNAL OF IMMUNOLOGY
    26. Kikuchi, T; Joki, T; Saitoh, S; Hata, Y; Abe, T; Kato, N; Kobayashi, A; Miyazaki, T; Ohno, T
      Anti-tumor activity of interleukin-2-producing tumor cells and recombinantinterleukin 12 against mouse glioma cells located in the central nervous system

      INTERNATIONAL JOURNAL OF CANCER
    27. Chamberlain, RS
      Prospects for the therapeutic use of anticancer vaccines

      DRUGS
    28. TAKEDA S; NAKAO A; MIYOSHI K; TAKAGI H
      GENE-THERAPY FOR PANCREATIC-CANCER

      Seminars in surgical oncology
    29. GAUTAM SC; PINDOLIA KR; XU YX; JANAKIRAMAN N; CHAPMAN RA; FREYTAG SO
      ANTILEUKEMIC ACTIVITY OF TNF-ALPHA GENE-THERAPY WITH MYELOID PROGENITOR CELLS AGAINST MINIMAL LEUKEMIA

      Journal of hematotherapy
    30. Zhang, RS; Baunoch, D; DeGroot, LJ
      Genetic immunotherapy for medullary thyroid carcinoma: Destruction of tumors in mice by in vivo delivery of adenoviral vector transducing the murine interleukin-2 gene

      THYROID
    31. NIGAM A; YACAVONE RF; ZAHURAK ML; JOHNS CMS; PARDOLL DM; PIANTADOSI S; LEVITSKY H; NELSON WG
      IMMUNOMODULATORY PROPERTIES OF ANTINEOPLASTIC DRUGS ADMINISTERED IN CONJUNCTION WITH GM-CSF-SECRETING CANCER CELL VACCINES

      International journal of oncology
    32. ESANDI MC; VANSOMEREN GD; BOUT A; MULDER AH; VANBEKKUM DW; VALERIO D; NOTEBOOM JL
      IL-1 IL-3 GENE-THERAPY OF NONSMALL CELL LUNG-CANCER (NSCLC) IN RATS USING CRACKED ADENOPRODUCER CELLS/

      Gene therapy
    33. Taniguchi, F; Yamagishi, H; Fujiwara, H; Ueda, Y; Fuji, N; Yoshimura, T; Oka, T
      Systemic administration of rIL-12 synergistically enhances the therapeuticeffect of a TNF gene-transduced cancer vaccine

      GENE THERAPY
    34. SUN TD; CARRBRENDEL V; DEZOETEN EF; COHEN EP
      IMMUNIZATION WITH INTERLEUKIN-2-SECRETING ALLOGENEIC CELLS TRANSFECTED WITH DNA FROM MOUSE MELANOMA-CELLS INDUCES IMMUNE-RESPONSES THAT PROLONG THE LIVES OF MICE WITH MELANOMA

      Cancer gene therapy
    35. CORRIAS MV; BASSO S; MEAZZA R; MUSIANI P; SANTI L; BOCCA P; OCCHINO M; FERRINI S; PISTOIA V
      CHARACTERIZATION AND TUMORIGENICITY OF HUMAN NEUROBLASTOMA-CELLS TRANSFECTED WITH THE IL-2 GENE

      Cancer gene therapy
    36. DUBINETT SM; MILLER PW; SHARMA S; BATRA RK
      GENE-THERAPY FOR LUNG-CANCER

      Hematology/oncology clinics of North America
    37. DEVOS S; KOHN DB; CHO SK; MCBRIDE WH; SAID JW; KOEFFLER HP
      IMMUNOTHERAPY AGAINST MURINE LEUKEMIA

      Leukemia
    38. Simons, JW; Mikhak, B
      Ex vivo gene therapy using cytokine-transduced tumor vaccines: Molecular and clinical pharmacology

      SEMINARS IN ONCOLOGY
    39. DEZOETEN EF; CARRBRENDEL V; COHEN EP
      RESISTANCE TO MELANOMA IN MICE IMMUNIZED WITH SEMIALLOGENEIC FIBROBLASTS TRANSFECTED WITH DNA FROM MOUSE MELANOMA-CELLS

      The Journal of immunology
    40. YOON SJ; HEO DS; KANG JO; LEE SG; KIM CD; SUNG MW; KIM NK
      SYNERGISTIC ANTITUMOR EFFECTS WITH COEXPRESSION OF GM-CSF AND IFN-GAMMA IN MURINE TUMORS

      International journal of cancer
    41. WANG J; YANG WK; YANG YL; WEI SJ; YANG DM; WHANGPENG J; CHEN YM; TING KL; TING CC
      PARADOXICAL EFFECT OF GM-CSF GENE-TRANSFER ON THE TUMORIGENICITY AND IMMUNOGENICITY OF MURINE TUMORS

      International journal of cancer
    42. MORECKI S; LUBINASALOMON A; SLAVIN S; NAGLER A
      CYTOKINE GENE TRANSDUCTION INTO NON-IMMUNOGENEIC MURINE TUMOR-CELLS

      Cytokines cellular & molecular therapy
    43. KIRCHEIS R; KUPCU Z; WALLNER G; WAGNER E
      CYTOKINE GENE-MODIFIED TUMOR-CELLS FOR PROPHYLACTIC AND THERAPEUTIC VACCINATION - IL-2, IFN-GAMMA, OR COMBINATION IL-2-GAMMA(IFN)

      Cytokines cellular & molecular therapy
    44. BRAUN SE; CHEN KY; BATTIWALLA M; CORNETTA K
      GENE-THERAPY STRATEGIES FOR LEUKEMIA

      Molecular medicine today
    45. TOLOZA EM; HUNT K; MILLER AR; MCBRIDE W; LAU R; SWISHER S; RHOADES K; ARTHUR J; CHOI J; CHEN L; CHANG PP; CHEN A; GLASPY J; ECONOMOU JS
      TRANSDUCTION OF MURINE AND HUMAN TUMORS USING RECOMBINANT ADENOVIRUS VECTORS

      Annals of surgical oncology
    46. CLARY BM; COVENEY EC; BLAZER DG; PHILIP R; PHILIP M; MORSE M; GILBOA E; LYERLY HK
      ACTIVE IMMUNIZATION WITH TUMOR-CELLS TRANSDUCED BY A NOVEL AAV PLASMID-BASED GENE DELIVERY SYSTEM

      Journal of immunotherapy with emphasis on tumor immunology
    47. LEE CT; WU S; CIERNIK IF; CHEN HL; NADAFRAHROV S; GABRILOVICH D; CARBONE DP
      GENETIC IMMUNOTHERAPY OF ESTABLISHED TUMORS WITH ADENOVIRUS-MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR

      Human gene therapy
    48. HSIEH CL; PANG VF; CHEN DS; HWANG LH
      REGRESSION OF ESTABLISHED MOUSE LEUKEMIA BY GM-CSF-TRANSDUCED TUMOR VACCINE - IMPLICATIONS FOR CYTOTOXIC T-LYMPHOCYTE RESPONSES AND TUMOR BURDENS

      Human gene therapy
    49. DRANOFF G; SOIFFER R; LYNCH T; MIHM M; JUNG K; KOLESAR K; LIEBSTER L; DUDA R; MENTZER S; SINGER S; TANABE K; JOHNSON R; SOBER A; BHAN A; CLIFT S; COHEN L; PARRY G; ROKOVICH J; RICHARDS L; DRAYER J; BERNS A; MULLIGAN RC
      A PHASE-I STUDY OF VACCINATION WITH AUTOLOGOUS, IRRADIATED MELANOMA-CELLS ENGINEERED TO SECRETE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR

      Human gene therapy
    50. POPE IM; POSTON GJ; KINSELLA AR
      THE ROLE OF THE BYSTANDER EFFECT IN SUICIDE GENE-THERAPY

      European journal of cancer
    51. HWU P
      CURRENT CHALLENGES IN CANCER GENE-THERAPY

      Journal of internal medicine
    52. XIANG J; QI YM; CHEN Y
      INHIBITION OF ESTABLISHED TUMOR-GROWTH IN SYNGENEIC MICE BY LOCAL INOCULATION OF ENGINEERED MOUSE MYELOMA CELLS SECRETING A RECOMBINANT FUSION PROTEIN RM4 TNF/

      Cancer gene therapy
    53. CLARY BM; COVENEY EC; PHILIP R; BLAZER DG; MORSE M; GILBOA E; LYERLY HK
      INHIBITION OF ESTABLISHED PANCREATIC CANCERS FOLLOWING SPECIFIC ACTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 GENE-TRANSDUCED TUMOR-CELLS

      Cancer gene therapy
    54. ABDELWAHAB Z; DAR M; OSANTO S; FONG T; VERVAERT CE; HESTER D; JOLLY D; SEIGLER HF
      ERADICATION OF MELANOMA PULMONARY METASTASES BY IMMUNOTHERAPY WITH TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-2 OR GAMMA-INTERFERON

      Cancer gene therapy
    55. LEBKOWSKI JS; PHILIP R; OKARMA TB
      BREAST-CANCER - CELL AND GENE-THERAPY

      Cancer investigation
    56. CORNETTA K; FAN Y
      RETROVIRAL GENE-THERAPY IN HEMATOPOIETIC DISEASES

      Journal of clinical apheresis
    57. ROSENTHAL FM; MERTELSMANN R
      PRESENT STRATEGIES FOR GENE-THERAPY IN CANCER

      Onkologie
    58. BARNES MN; DESHANE JS; ROSENFELD M; SIEGAL GP; CURIEL DT; ALVAREZ RD
      GENE-THERAPY AND OVARIAN-CANCER - A REVIEW

      Obstetrics and gynecology
    59. ABDELWAHAB Z; WELTZ C; HESTER D; PICKETT N; VERVAERT C; BARBER JR; JOLLY D; SEIGLER HF
      A PHASE-I CLINICAL-TRIAL OF IMMUNOTHERAPY WITH INTERFERON-GAMMA GENE-MODIFIED AUTOLOGOUS MELANOMA-CELLS - MONITORING THE HUMORAL IMMUNE-RESPONSE

      Cancer
    60. HALL SJ; CHEN SH; WOO SLC
      THE PROMISE AND REALITY OF CANCER GENE-THERAPY

      American journal of human genetics
    61. ANDERSON PM
      DELIVERY SYSTEMS FOR IMMUNOMODULATORY PROTEINS AND PEPTIDES

      Biodrugs
    62. BIGNON YJ; DINCAN C; DINCAN M; SOUTEYRAND P
      GENE-THERAPY - ITS PRESENT AND FUTURE IN DERMATOLOGY

      EJD. European journal of dermatology
    63. ORCHARD PJ; KATSANIS E; BOYER M; MAY C; MCIVOR RS; BLAZAR BR
      INTERLEUKIN-2 SECRETION BY TRANSDUCED AND UNSELECTED BDL-2 LYMPHOMA RESULTS IN INCREASED SURVIVAL IN MICE WITH PREVIOUSLY ESTABLISHED DISSEMINATED DISEASE

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    64. CAMP BJ; DYHRMAN ST; MEMOLI VA; MOTT LA; BARTH RJ
      IN-SITU CYTOKINE PRODUCTION BY BREAST-CANCER TUMOR-INFILTRATING LYMPHOCYTES

      Annals of surgical oncology
    65. PEPLINSKI GR; TSUNG K; MEKO JB; NORTON JA
      PREVENTION OF MURINE BREAST-CANCER BY VACCINATION WITH TUMOR-CELLS MODIFIED BY CYTOKINE-PRODUCING RECOMBINANT VACCINIA VIRUSES

      Annals of surgical oncology
    66. BAUSERO MA; PANOSKALTSISMORTARI A; BLAZAR BR; KATSANIS E
      EFFECTIVE IMMUNIZATION AGAINST NEUROBLASTOMA USING DOUBLE-TRANSDUCED TUMOR-CELLS SECRETING GM-CSF INTERFERON-GAMMA

      Journal of immunotherapy with emphasis on tumor immunology
    67. STINGL G; BROCKER EB; MERTELSMANN R; WOLFF K; SCHREIBER S; KAMPGEN E; SCHNEEBERGER A; DUMMER W; BRENNSCHEID U; VEELKEN H; BIRNSTIEL ML; ZATLOUKAL K; SCHMIDT W; MAASS G; WAGNER E; BUSCHLE M; GIESE M; KEMPE ER; WEBER HA; VOIGT T
      PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE

      Human gene therapy
    68. CHANG AE; SHU SY
      CURRENT STATUS OF ADOPTIVE IMMUNOTHERAPY OF CANCER

      Critical reviews in oncology/hematology
    69. WANG J; WEI SJ; YANG WK; LIN WC; YANG DM; WHANGPENG J; TING CC
      IN-VITRO AND IN-VIVO CORRELATION OF THE EFFECT OF GRANULOCYTEMACROPHAGE COLONY-STIMULATING FACTOR GENE-TRANSFER ON THE TUMORIGENICITY AND IMMUNOGENICITY OF B16 MELANOMA

      International journal of oncology
    70. ABINA MA; LEE MG; DESCAMPS V; CORDIER L; LOPEZ M; PERRICAUDET M; HADDADA H
      LACZ GENE-TRANSFER INTO TUMOR-CELLS ABROGATES TUMORIGENICITY AND PROTECTS MICE AGAINST THE DEVELOPMENT OF FURTHER TUMORS

      Gene therapy
    71. QIN HX; CHATTERJEE SK
      CONSTRUCTION OF RECOMBINANT VACCINIA VIRUS EXPRESSING GM-CSF AND ITS USE AS TUMOR VACCINE

      Gene therapy
    72. CIOTTI P; IMRO A; SCUDELETTI M; RAINERO ML; DEFFERRARI R; GHIORZO P; INDIVERI F; BIANCHISCARRA G
      MEL-P, A GM-CSF-PRODUCING HUMAN-MELANOMA CELL-LINE

      Melanoma research
    73. DALGLEISH A
      THE CASE FOR THERAPEUTIC VACCINES

      Melanoma research
    74. ZIER KS; GANSBACHER B
      TUMOR-CELL VACCINES THAT SECRETE INTERLEUKIN-2 (IL-2) AND INTERFERON-GAMMA (IFN-GAMMA) ARE RECOGNIZED BY T-CELLS WHILE RESISTING DESTRUCTION BY NATURAL-KILLER (NK) CELLS

      European journal of cancer
    75. DESCAMPS V; DUFFOUR MT; MATHIEU MC; FERNANDEZ N; CORDIER L; ABINA MA; KREMER E; PERRICAUDET M; HADDADA H
      STRATEGIES FOR CANCER GENE-THERAPY USING ADENOVIRAL VECTORS

      Journal of molecular medicine
    76. ZIER KS; GANSBACHER B
      IL-2 GENE-THERAPY OF SOLID TUMORS - AN APPROACH FOR THE PREVENTION OFSIGNAL-TRANSDUCTION DEFECTS IN T-CELLS

      Journal of molecular medicine
    77. QIN HX; CHATTERJEE SK
      RECOMBINANT VACCINIA EXPRESSING INTERLEUKIN-2 FOR CANCER GENE-THERAPY

      Cancer gene therapy
    78. PARKER SE; KHATIBI S; MARGALITH M; ANDERSON D; YANKAUCKAS M; GROMKOWSKI SH; LATIMER T; LEW D; MARQUET M; MANTHORPE M; HOBART P; HERSH E; STOPECK AT; NORMAN J
      PLASMID DNA GENE-THERAPY - STUDIES WITH THE HUMAN INTERLEUKIN-2 GENE IN TUMOR-CELLS IN-VITRO AND IN THE MURINE B16 MELANOMA MODEL IN-VIVO

      Cancer gene therapy
    79. HUSSEIN AM
      THE POTENTIAL APPLICATIONS OF GENE-TRANSFER IN THE TREATMENT OF PATIENTS WITH CANCER - A CONCISE REVIEW

      Cancer investigation
    80. ARCA MJ; KRAUSS JC; STROME SE; CAMERON MJ; CHANG AE
      DIVERSE MANIFESTATIONS OF TUMORIGENICITY AND IMMUNOGENICITY DISPLAYEDBY THE POORLY IMMUNOGENIC B16-BL6 MELANOMA TRANSDUCED WITH CYTOKINE GENES

      Cancer immunology and immunotherapy
    81. JU DW; CAO XT; ACRES B
      ACTIVE SPECIFIC IMMUNOTHERAPY OF PULMONARY METASTASIS WITH VACCINIA MELANOMA ONCOLYSATE PREPARED FROM GRANULOCYTE MACROPHAGE COLONY-STIMULATING-FACTOR-GENE-ENCODED VACCINIA VIRUS/

      Journal of cancer research and clinical oncology
    82. BENAIM E; SORRENTINO BP
      GENE-THERAPY IN PEDIATRIC ONCOLOGY

      Investigational new drugs
    83. ZIER K; GANSBACHER B; SALVADORI S
      PREVENTING ABNORMALITIES IN SIGNAL-TRANSDUCTION OF T-CELLS IN CANCER - THE PROMISE OF CYTOKINE GENE-THERAPY

      Immunology today
    84. GILBOA E
      IMMUNOTHERAPY OF CANCER WITH GENETICALLY-MODIFIED TUMOR VACCINES

      Seminars in oncology
    85. COOPER MJ
      NONINFECTIOUS GENE-TRANSFER AND EXPRESSION SYSTEMS FOR CANCER GENE-THERAPY

      Seminars in oncology
    86. CLARY BM; COVENEY EC; BLAZER DG; PHILIP R; LYERLY HK
      ACTIVE IMMUNOTHERAPY OF PANCREATIC-CANCER WITH TUMOR-CELLS GENETICALLY-ENGINEERED TO SECRETE MULTIPLE CYTOKINES

      Surgery
    87. SAMPSON JH; ARCHER GE; ASHLEY DM; FUCHS HE; HALE LP; DRANOFF G; BIGNER DD
      SUBCUTANEOUS VACCINATION WITH IRRADIATED, CYTOKINE-PRODUCING TUMOR-CELLS STIMULATES CD8(-MEDIATED-IMMUNITY AGAINST TUMORS LOCATED IN THE IMMUNOLOGICALLY PRIVILEGED CENTRAL-NERVOUS-SYSTEM() CELL)

      Proceedings of the National Academy of Sciences of the United Statesof America
    88. ZHAO Z; LEONG KW
      CONTROLLED DELIVERY OF ANTIGENS AND ADJUVANTS IN VACCINE DEVELOPMENT

      Journal of pharmaceutical sciences
    89. OHNO K; YOSHIZAWA H; TSUKADA H; TAKEDA T; YAMAGUCHI Y; ICHIKAWA K; MARUYAMA Y; SUZUKI Y; SUZUKI E; ARAKAWA M
      ADOPTIVE IMMUNOTHERAPY WITH TUMOR-SPECIFIC T-LYMPHOCYTES GENERATED FROM CYTOKINE GENE-MODIFIED TUMOR-PRIMED LYMPH-NODE CELLS

      The Journal of immunology
    90. TOPF N; SCHMIEGEL WH
      IMMUNE THERAPY WITH GENETICALLY-MODIFIED TUMOR-CELLS

      Der Internist
    91. GUCKEL B; MOEBIUS U; MEUER S; KAUL S; BASTERT G; WALLWIENER D
      DEVELOPMENT OF IMMUNOGENIC BREAST AND OVA RIAN TUMOR-CELLS FOR VACCINATION

      Geburtshilfe und Frauenheilkunde
    92. DEWIT D; FLEMMING CL; HARRIS JD; PALMER KJ; MOORE JS; GORE ME; COLLINS MKL
      IL-12 STIMULATION BUT NOT B7 EXPRESSION INCREASES MELANOMA KILLING BYPATIENT CYTOTOXIC T-LYMPHOCYTES (CTL)

      Clinical and experimental immunology
    93. ABDELWAHAB Z; DAR MM; HESTER D; VERVAERT C; GANGAVALLI R; BARBER J; DARROW TL; SEIGLER HF
      EFFECT OF IRRADIATION ON CYTOKINE PRODUCTION, MHC ANTIGEN EXPRESSION,AND VACCINE POTENTIAL OF INTERLEUKIN-2 AND INTERFERON-GAMMA GENE-MODIFIED MELANOMA-CELLS

      Cellular immunology
    94. MORITA T; IKEDA K; DOUZONO M; YAMADA M; KIMURA F; KAWAKAMI K; SASAKI K; MOTOYOSHI K; TAKAHARA J; IRINO S
      TUMOR VACCINATION WITH MACROPHAGE-COLONY-STIMULATING FACTOR-PRODUCINGLEWIS LUNG-CARCINOMA IN MICE

      Blood
    95. FORNI G; CAVALLO F; CONSALVO M; ALLIONE A; DELLABONA P; CASORATI G; GIOVARELLI M
      MOLECULAR APPROACHES TO CANCER-IMMUNOTHERAPY

      Cytokines and molecular therapy
    96. GUCKEL B; LINDAUER M; RUDY W; HABICHT A; SIEBELS M; KAUL S; BASTERT G; MEUER SC; MOEBIUS U
      CD80-TRANSFECTED HUMAN BREAST AND OVARIAN TUMOR-CELL LINES - IMPROVEDIMMUNOGENICITY AND INDUCTION OF CYTOLYTIC CD8(-LYMPHOCYTES() T)

      Cytokines and molecular therapy
    97. MATORY YL; CHEN M; GOEDEGEBUURE PS; EBERLEIN TJ
      ANTITUMOR EFFECTS AND TUMOR IMMUNOGENICITY FOLLOWING IL2 OR IL4 CYTOKINE GENE TRANSFECTION OF 3 MOUSE MAMMARY-TUMORS

      Annals of surgical oncology
    98. HOCK RA; REYNOLDS BD; TUCKERMCCLUNG CL; KWOK WW
      HUMAN CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX GENE-TRANSFER INTO MURINE NEUROBLASTOMA LEADS TO LOSS OF TUMORIGENICITY, IMMUNITY AGAINST SUBSEQUENT TUMOR CHALLENGE, AND ELIMINATION OF MICROSCOPIC PREESTABLISHED TUMORS

      Journal of immunotherapy with emphasis on tumor immunology
    99. MACKIEWICZ A; WIZNEROWICZ M; ROEB E; KARCZEWSKA A; NOWAK J; HEINRICH PC; ROSEJOHN S
      SOLUBLE INTERLEUKIN-6 RECEPTOR IS BIOLOGICALLY-ACTIVE IN-VIVO

      Cytokine
    100. HABICHT A; LINDAUER M; GALMBACHER P; RUDY W; GEBERT J; SCHACKERT HK; MEUER SC; MOEBIUS U
      DEVELOPMENT OF IMMUNOGENIC COLORECTAL-CANCER CELL-LINES FOR VACCINATION - EXPRESSION OF CD80 (B7.1) IS NOT SUFFICIENT TO RESTORE IMPAIRED PRIMARY T-CELL ACTIVATION IN-VITRO

      European journal of cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 14:35:08